GlassScriptPhysician profile
Samantha Dodda
NPI 1104443720
$2,089.24
in general payments reported to CMS, 2019-2025
19 companies · $122 in 2025
The $122 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $187 · 2022: $1,100 · 2023: $664 · 2024: $16.34 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $803.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $802.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $463.09 | 2022-2023 | Lumigan, Alphagan P, Vuity |
| Bausch & Lomb Americas INC. | $233.52 | 2022-2024 | Xiidra, Miebo |
| Allergan, INC. | $167.19 | 2021-2022 | |
| Biotissue Holdings INC. | $157.24 | 2022-2025 | |
| Lumenis Be INC | $142.63 | 2022 | |
| Novartis Pharmaceuticals Corporation | $119.69 | 2021-2023 | |
| Oyster Point Pharma, INC. | $104.81 | 2022-2023 | Tyrvaya |
| Glaukos Corporation | $90.18 | 2023 | |
| Lkc Technologies, INC. | $82.46 | 2025 | |
| Carl Zeiss Meditec USA, INC. | $76.02 | 2023 | |
| Dompe US, INC. | $66.23 | 2021-2022 | |
| Rxsight INC | $62.77 | 2023 | Rxsight Injector Cartridge, Rxsight Light Adjustable Lens (Rxlal), Rxsight Contact Lens |
| Thea Pharma INC. | $61.76 | 2022-2023 | |
| Kala Pharmaceuticals, INC. | $59.20 | 2021-2022 | |
| Mallinckrodt Hospital Products INC. | $51.93 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $48.64 | 2021 | |
| Akorn Operating Company LLC | $42.41 | 2021 | |
| Eyevance Pharmaceuticals LLC | $40.78 | 2022-2023 | Flarex |
| Sight Sciences, INC. | $18.69 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samantha Dodda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.